Depression During Pregnancy is Associated with Abnormal Brain Structure in Children
Reports new study in Biological Psychiatry
Reports new study in Biological Psychiatry
Depressive symptoms in women during and after pregnancy are associated with reduced thickness of the cortex—the outer layer of the brain responsible for complex thought and behavior—in preschool-age kids, according to a new study published in Biological Psychiatry. The findings suggest that a mother’s mood may affect her child’s brain development at critical stages in life.
“Mothers generally want to do everything they can to give their offspring the best possible chance of success in life. They often make sure to eat well and to take special vitamins,” said John Krystal, Editor of Biological Psychiatry. “This new study now suggests that another thing they may be able to do is to make sure that they are treated for their depression.”
Eighteen percent of women experience depression some time during pregnancy, and both perinatal and postpartum depression have been associated with negative outcomes in children. The new study, led by Catherine Lebel of the University of Calgary in Alberta, is the first to report associations between maternal depression and abnormal brain structure in kids at this age.
The researchers screened 52 women for depressive symptoms during each trimester of pregnancy and a few months after the child was born. The women ranged in the presence of symptoms, some with no or few symptoms, and some meeting the screening criteria for depression. When the children reached about 2.5 to 5 years old, the researchers used magnetic resonance imaging to measure their brain structure.
Women with higher depressive symptoms tended to have children with thinner frontal and temporal areas, cortical regions implicated in tasks involving inhibition and attention control. The researchers also found an association between depressive symptoms and abnormal white matter in the frontal area, the fiber tracts connecting the region to other areas in the brain.
These associations were only found when symptoms occurred during the second trimester and postpartum, suggesting these periods are particularly critical times for child brain development.
Cortical thinning is a normal aspect of brain development during early childhood, so Lebel says the findings suggest that the brain may be developing prematurely in children whose mothers experience more depressive symptoms.
Abnormalities in brain structure during critical periods in development have often been associated with negative outcomes, such as learning disabilities and behavioral disorders. Additionally, the brain structure abnormalities identified in this study reflect those found in children with depression or at high risk for developing the disorder, suggesting that these alterations may be why children of mothers with perinatal depression are more vulnerable to depression later in life.
Although the mechanism behind the association remains a mystery, the findings may have implications for minimizing risks of atypical brain development in children.
“Our findings underscore the importance of monitoring and supporting mental health in mothers not just in the postpartum period, but also during pregnancy,” said Lebel.
Notes for editors
The article is "Prepartum and Postpartum Maternal Depressive Symptoms Are Related to Children’s Brain Structure in Preschool," by Catherine Lebel, Matthew Walton, Nicole Letourneau, Gerald F. Giesbrecht, Bonnie J. Kaplan, and Deborah Dewey (doi: 10.1016/j.biopsych.2015.12.004). It appears in Biological Psychiatry, volume 80, issue 11 (2016), published by Elsevier.
Copies of this paper are available to credentialed journalists upon request; please contact Rhiannon Bugno at +1 214 648 0880 or email@example.com. Journalists wishing to interview the authors may contact Catherine Lebel, Ph.D. at firstname.lastname@example.org.
The authors’ affiliations, and disclosures of financial and conflicts of interests are available in the article.
John H. Krystal, M.D., is Chairman of the Department of Psychiatry at the Yale University School of Medicine, Chief of Psychiatry at Yale-New Haven Hospital, and a research psychiatrist at the VA Connecticut Healthcare System. His disclosures of financial and conflicts of interests are available here.
About Biological Psychiatry
Biological Psychiatry is the official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes both basic and clinical contributions from all disciplines and research areas relevant to the pathophysiology and treatment of major psychiatric disorders.
The journal publishes novel results of original research which represent an important new lead or significant impact on the field, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Reviews and commentaries that focus on topics of current research and interest are also encouraged.
Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. It is ranked 5th out of 140 Psychiatry titles and 11th out of 256 Neurosciences titles in the Journal Citations Reports® published by Thomson Reuters. The 2015 Impact Factor score for Biological Psychiatry is 11.212.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
Editorial Office, Biological Psychiatry
+1 214 648 0880